Cullinan Oncology, Inc.·4

Dec 22, 5:30 PM ET

Jones Jeffrey Alan 4

4 · Cullinan Oncology, Inc. · Filed Dec 22, 2023

Insider Transaction Report

Form 4
Period: 2023-12-21
Jones Jeffrey Alan
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2023-12-21$8.50/sh1,860$15,81056,191 total
Footnotes (1)
  • [F1]Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4